Skip to main content
SpringerLink
Log in

Pleura, Chest Wall, Lung, and Mediastinum

  • Chapter
  • First Online:
Palliative Surgery

  • 1040 Accesses

Abstract

An objective approach to the surgical palliation of pleural, pulmonary, and mediastinal malignancy with a focus on minimally invasive, low-morbidity techniques

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wildgaard K, Ravn J, Kehlet H. Chronic post-thoracotomy pain: a critical review of pathogenic mechanisms and strategies for prevention. Eur J Cardiothorac Surg. 2009;36(1):170–80.

    Article  PubMed  Google Scholar 

  2. Heffner JE. Diagnosis and management of malignant pleural effusions. Respirology. 2008;13:5–20.

    Article  PubMed  Google Scholar 

  3. Bernard A, de Dompsure RB, Hagry O, et al. Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg. 2002;74:213–7.

    Article  PubMed  Google Scholar 

  4. Dresler CM, Olak J, Herndon II JE, et al. Phase III intergroup study of talc poudrage vs. talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127:909–15.

    Article  PubMed  Google Scholar 

  5. Stefani A, Natali P, Casali C, Morandi U. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Eur J Cardiothorac Surg. 2006;30(6):827–32.

    Article  PubMed  Google Scholar 

  6. Lee P. Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes. Chest. 2012;142(1):15–7.

    PubMed  Google Scholar 

  7. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120:56–64.

    Article  CAS  PubMed  Google Scholar 

  8. Tan C, Sedrakyan A, Browne J, et al. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg. 2006;29:829–38.

    Article  PubMed  Google Scholar 

  9. Colt HG, Davoudi M. The ideal pleurodesis agent: still searching after all these years. Lancet Oncol. 2008;9:912–3.

    Article  PubMed  Google Scholar 

  10. Efthymiou CA, Masudi T, Thorpe JA, Papagiannopoulos K. Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunneled catheters. Interact Cardiovasc Thorac Surg. 2009;9(6):961–4.

    Article  PubMed  Google Scholar 

  11. Fysh ET, Waterer GW, Kendall P, Bremner P, Dina S, Geelhoed E, et al. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest. 2012;142(2):394–400.

    Article  PubMed  Google Scholar 

  12. Davies H, Mishra E, Wrightson J, Stanton A. The second therapeutic intervention in Malignant Effusion Trial (TIME2): a randomized controlled trial to assess the efficacy and safety of patient controlled malignant pleural effusion by indwelling pleural catheter compared to chest tube and Talc Slurry. Am J Respir Crit Care Med. 2012;185:6860.

    Google Scholar 

  13. Tsao AS, Witsuba I, Roth JA, Kindler HL. Malignant pleural mesothelioma. J Clin Oncol. 2009;27:2081–90.

    Article  CAS  PubMed  Google Scholar 

  14. Kaufman AJ, Flores RM. Surgical treatment of malignant pleural mesothelioma. Curr Treat Options Oncol. 2011;12:201–16.

    Article  PubMed  Google Scholar 

  15. Kindler HL. Surgery for mesothelioma? The debate continues. Lancet Oncol. 2011;12:713–4.

    Article  PubMed  Google Scholar 

  16. Rice D. Surgical therapy of mesothelioma. Recent results. Cancer Res. 2011;189:97–125.

    Google Scholar 

  17. Maziak DE, Gagliardi A, Haynes AE, et al. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer. 2005;48:157–69.

    Article  PubMed  Google Scholar 

  18. Rice D, Rusch V, Passh H, et al. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group. J Thorac Oncol. 2011;6:1304–12.

    Article  PubMed  Google Scholar 

  19. Tsao S, Witsuba I, Hasani A, Alvarez JM, Wyatt JM, et al. Outcome for patients with malignant pleural mesothelioma referred for tri-modality therapy in Western Australia. J Thorac Oncol. 2009;4:1110–6.

    Google Scholar 

  20. Thomford N, Woolner L, Clagett O. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg. 1965;49:357–63.

    CAS  PubMed  Google Scholar 

  21. Roth J, Pass H, Wesley M, White D, Putnam I. Comparison of median sternotomy and thoracotomy for resection of pulmonary metastases in patients with adult soft-tissue sarcomas. Ann Thorac Surg. 1986;42:134–8.

    Article  CAS  PubMed  Google Scholar 

  22. Vogt-Moykopf I, Krysa S, Bülzebruck H, Schirren J. Surgery for pulmonary metastases. The Heidelberg experience. Chest Surg Clin N Am. 1994;4:85–112.

    CAS  PubMed  Google Scholar 

  23. Pfannschmidt J, Hoffmann H, Dienemann H. Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J Thorac Oncol. 2010;5(6 Suppl 2):S172–8.

    Article  PubMed  Google Scholar 

  24. Neeff H, Hörth W, Makowiec F, Fischer E. Outcome after resection of hepatic and pulmonary metastases of colorectal cancer. J Gastrointest Surg. 2009;13:1813–20.

    Article  PubMed  Google Scholar 

  25. Meimarakis G, Angele M, Schneider C, Weidenhagen R, Kalaitzis N, Molki A, et al. Bedeutung der systematischen Lymphknoten-dissektion im Rahmen der Resektion pulmonaler Metastasen solider extrapulmonaler Tumoren. Zentralbl Chir. 2010;135:556–63.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiothoracic Surgery Unit, Royal Adelaide Hospital, North Terrace, Adelaide, SA, 5066, Australia

    Craig A. Jurisevic MBBS, MS, FRACS

Authors
  1. Craig A. Jurisevic MBBS, MS, FRACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Craig A. Jurisevic MBBS, MS, FRACS .

Editor information

Editors and Affiliations

  1. Department of General Surgery, Mount Gambier General Hospital, Flinders University—Rural Medical School, Mount Gambier, South Australia, Australia

    Matthias W. Wichmann

  2. Discipline of Surgery, The Queen Elizabeth Hospital, University of Adelaide, Woodville, South Australia, Australia

    Guy Maddern

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jurisevic, C.A. (2014). Pleura, Chest Wall, Lung, and Mediastinum. In: Wichmann, M., Maddern, G. (eds) Palliative Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-53709-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-53709-7_19

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-53708-0

  • Online ISBN: 978-3-642-53709-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation